RETfusion gene: Translation to personalized lung cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RETfusion gene: Translation to personalized lung cancer therapy

Published:2013-10-01 Issue:11 Volume:104 Page:1396-1400
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kohno Takashi¹²,Tsuta Koji³,Tsuchihara Katsuya¹,Nakaoku Takashi²,Yoh Kiyotaka⁴,Goto Koichi⁴

Affiliation:

1. Division of Translational Research; Exploratory Oncology Research & Clinical Trial Center (EPOC); National Cancer Center; Tokyo Japan

2. Division of Genome Biology; National Cancer Center Research Institute; Tokyo Japan

3. Division of Pathology and Clinical Laboratories; National Cancer Center Hospital; Tokyo Japan

4. Division of Thoracic Oncology; National Cancer Center Hospital East; Kashiwa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12275/fullpdf

Reference31 articles.

1. Cancer statistics, 2010;Jemal;CA Cancer J Clin,2010

2. New targetable oncogenes in non-small-cell lung cancer;Oxnard;J Clin Oncol,2013

3. Chipping away at the lung cancer genome;Pao;Nat Med,2012

4. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing;Imielinski;Cell,2012

5. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR;Maemondo;N Engl J Med,2010

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. It might be a dead end: immune checkpoint inhibitor therapy in EGFR-mutated NSCLC;Exploration of Targeted Anti-tumor Therapy;2024-07-19

2. The rapidly changing field of predictive biomarkers of non-small cell lung cancer;Pathology and Oncology Research;2024-06-17

3. CCDC6-RET fusion protein regulates Ras/MAPK signaling through the fusion- GRB2-SHC1 signal niche;Proceedings of the National Academy of Sciences;2024-05-28

4. Targeted Molecular Profiling of Non-small Cell Lung Cancer in India;Journal of Advanced Immunopharmacology;2024-03-17

5. A macrocyclic kinase inhibitor overcomes triple resistant mutations in EGFR-positive lung cancer;npj Precision Oncology;2024-02-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3